Login
$LNSR
$5.29 +$0.29 (5.8%) Live

$LNSR 8-K SEC Filings

Filed On Filing
10 Nov 2026 8-K: Results of Operations and Financial Condition

10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Third Quarter 2026; Backlog of 12 ALLY Systems as of September 30, 2026

13 Aug 2026 8-K: Results of Operations and Financial Condition

10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026

10 Aug 2026 8-K: Submission of Matters to a Vote of Security Holders

On August 4, 2026, LENSAR, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). At the close of business on June 10, 2026, the record date for the Annual Meeting (the “Record Date”), 12,281,581 shares of t...

29 May 2026 8-K: Departure/Election of Directors or Officers; Compensation; Shareholder Director Nominations +1 more

On May 25, 2026, the Board of Directors (the “Board”) of LENSAR, Inc. (the “Company”) appointed Michael A. Rossi to serve as the Company’s Interim Chief Financial Officer and principal financial officer, effective as of May 29, 2026.

08 May 2026 8-K: Results of Operations and Financial Condition

7 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026

15 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation

On April 10, 2026, Thomas R. Staab, II, Chief Financial Officer of LENSAR, Inc. (the “Company”), notified the Company of his intention to resign from this position, effective May 8, 2026 (the “Transition Date”), to pursue other professio...

31 Mar 2026 8-K: Results of Operations and Financial Condition

15 ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 4Q 2025; Backlog of 13 ALLY Systems pending installation as of December 31, 2025

17 Mar 2026 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more

This TERMINATION AND MUTUAL RELEASE AGREEMENT is entered into as of March 16, 2026 (the “Agreement”), by and among Alcon Research, LLC, a Delaware limited liability company (“Parent”), VMI Option Merger Sub, Inc., a Delaware corporation ...

12 Mar 2026 8-K: Other Events

On March 12, 2026, LENSAR, Inc. (the “Company”) reported that it has entered into a Priority Credit Line Agreement, dated as of March 11, 2026 (the “PCL Agreement”), by and between the Company and Wells Fargo Bank, N.A (“Wells Fargo”). T...

25 Feb 2026 8-K: Regulation FD Disclosure

ORLANDO, Fla. (February 25, 2026) - LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today provided an update on the ...

19 Dec 2025 8-K: Submission of Matters to a Vote of Security Holders

On December 18, 2025, LENSAR, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). At the close of business on October 24, 2025, the record date for the Annual Meeting (the “Record Date”), 11,944,546 share...

06 Nov 2025 8-K: Results of Operations and Financial Condition

18 ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 3Q 2025; Backlog of 18 ALLY Systems pending installation as of September 30, 2025

21 Oct 2025 8-K: Shareholder Director Nominations; Other Events

To the extent applicable, the information in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.

07 Aug 2025 8-K: Results of Operations and Financial Condition

18 ALLY Robotic Cataract Laser Systems™ (“ALLY Systems”) placed in 2Q 2025 with an additional backlog of 18 ALLY Systems pending installation as of June 30, 2025

02 Jul 2025 8-K: Submission of Matters to a Vote of Security Holders

On July 2, 2025, LENSAR, Inc., a Delaware corporation (“LENSAR” or the “Company”), held a virtual special meeting of its stockholders (the “Special Meeting”) to vote on the proposals identified in the definitive proxy statement of LENSAR...

22 May 2025 8-K: Other Events

As previously announced, on March 23, 2025, LENSAR, Inc. (“LENSAR”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Alcon Research, LLC, a Delaware limited liability company (“Parent” or “Alcon”), and VMI Opti...

08 May 2025 8-K: Results of Operations and Financial Condition

14 ALLY Robotic Laser Cataract Systems™ (“ALLY Systems”) placed in 1Q 2025 with an additional backlog of 24 systems pending installation as of March 31, 2025

24 Mar 2025 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more

This AGREEMENT AND PLAN OF MERGER (this “Agreement”), made and entered into as of March 23, 2025 (the “Execution Date”), is entered into by and among Alcon Research, LLC, a Delaware limited liability company (“Parent”), VMI Option Merger...

27 Feb 2025 8-K: Results of Operations and Financial Condition

31 ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company’s total installed systems increased to approximately 385 as of December 31, 2024, representin...

07 Nov 2024 8-K: Results of Operations and Financial Condition

24 ALLY Robotic Laser Cataract Systems™ placed in 3Q 2024 including 11 sales in EU and Southeast Asia; Robust backlog with 24 systems pending installation as of September 30, 2024

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support